Discover and read the best of Twitter Threads about #cardioOb
Most recents (2)
1/Ms. Pregs is a G1P0 woman presenting to your clinic at 28 weeks. She has a history of hypertrophic cardiomyopathy (HCM). How should we manage her pregnancy?
Get ready for a fun #CardioObstetrics tweetorial from the @Cardionerds!
Get ready for a fun #CardioObstetrics tweetorial from the @Cardionerds!
2/I feel comfortable managing a pregnant patient who has HCM.
3/HCM is defined as LV wall thickness of ≥15 mm that is not explained by loading conditions (e.g., hypertension, valvular, congenital disease) or infiltrative cardiomyopathies.
Image: American Heart Assn
Image: American Heart Assn
1/ SGLT2 inhibition initiation in the acute hospital setting? This trial showed significant benefit — REGARDLESS of ejection fraction — safe, and with incrementally added benefit when started early. EMPULSE Trial, Nature Medicine, 2022 ♥️
2/ SGLT2 inhibition for HFpEF? This trial showed SGLT2 inhibitors to have mortality benefit with EF > 40%, regardless of diabetes status. HFpEF represents a population of patients that beyond diuretic use, has historically been difficult to treat. DELIVER Trial, NEJM 2022 ♥️
